Pancreatic cancer is most often caught late. On the latest PancChat, Dr. Ray Wadlow breaks down who should be screened, what genetic mutations to know about, and how the @PrecedeStudy is working to change early detection at a global scale.
Listen: youtu.be/LlaPFCDYz28
Learn more about the relationship between diabetes and pancreatic cancer, understand who might be at risk, and find out what to do if you are at risk. letswinpc.org/diabetes/
After you are diagnosed, your oncologist will discuss treatments. Learn more about the different types of chemotherapy, surgery, and radiation used to treat pancreatic cancer. bit.ly/3RDYvcv
Marla Schreffler tenía la sensación de que algo no estaba bien, aun después de que le diagnosticaran diabetes. Pruebas adicionales confirmaron que tenía cáncer de páncreas. bit.ly/4epvkDF
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you. bit.ly/4uWZ9C5
When Dr. Brian Wolpin read the final results from the phase III daraxonrasib trial, everyone was on their feet at the 2026 ASCO meeting. bit.ly/3RZWRnH
Dr. Despina Siolas @DrDespina123 is focusing her research on new treatments for pancreatic cancer, particularly ones that go after KRAS mutations. bit.ly/4xgaaQR
Pancreatic cancer will look very different in 5 years
✅ KRAS is no longer "undruggable"
✅ Neoantigen vaccines may stop recurrence
✅ AI can identify 'occult' tumors from routine scans
We tackle these stories in our new episode!
#onlyoncologistsinthebuilding
A potential breakthrough in pancreatic cancer treatment is giving physicians new hope.
“Having treated pancreatic cancer for 16 years, I actually started crying,” said Rachna Shroff, MD, MS. “It’s unprecedented.”
@rachnatshroff
Read more @pbsnewshour: to.pbs.org/4e4byxn
Imagine this:
If CROs and academic centers would allow clinical trials activation and enrollment in the US to be modernized, the KRAS plenary would have been presented in #asco25 and we would have three more RAS trial readouts by today.
ALT prove me wrong gordon ramsay GIF by MasterChef Junior
Accelerating time to trial activation to answer important clinical questions and improve standard of care to benefit patients more quickly - @AACI_Cancer - @asco stakeholders meeting with @FDAOncology@NCIDirector and many more! Lots of interest, time to turn that into action!
We need to better connect discovery to patients’ lived experience. Studies using wearable tech to track sleep in brain tumor patients are a powerful example—bringing real-world data into care and research to improve outcomes. go.nih.gov/3gpMVbV
ALT A woman using a smart watch while lying in bed. Researchers are using smart wearable devices to measure sleep, heart rate, and activity patterns. Credit: iStock
The first shipments of Daraxonrasib have arrived!
-given through the @RevMedicines EAP program
-authorized by the @FDA_Drug_Info
-welcomed by oncologists
-and appreciated by PDAC patients & families
Dr. @steveleeyc knows exactly when to bring his daughter into work for a historic moment!
A KRAS moment that will bring hope (and tears) to patients across the US.
@letswinpc@lustgartenfdn@kevansf@DavidHongMD@GarridoLagunaMD@Aiims1742
Finally got our first #pancreaticcancer patient onto #daraxonrasib through @RevMedicines@FDAOncology Expanded Access Program. Turned into an unplanned bring-your-daughter-to-work day to get same-day consent to start therapy. Fingers crossed!